A phase 3 randomised, placebo-controlled, double-blind study of Niraparib in combination with Abiraterone acetate and Prednisone versus Abiraterone acetate and Prednisone for treatment of subjects with metastatic prostate cancer [MAGNITUDE].

  • Pook, David (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

StatusActive
Effective start/end date29/07/19 → 31/12/24
View all
View less

Keywords

  • Medical Oncology
  • Prostrate Cancer
  • Clinical trial